Biological & Clinical Evaluation of Medical Devices
Elexes helps medical device manufacturers build defensible biological and clinical evaluation strategies, reports, and supporting evidence for global submissions. From biocompatibility planning and risk alignment to CER development and readiness reviews, our team helps reduce avoidable deficiencies, strengthen technical documentation, and move products toward market access with greater confidence.
Our Biological & Clinical Evaluation Services
Targeted support for evidence generation, evaluation reports, readiness reviews, and regulatory alignment across medical device submissions.
Clinical Evaluation Reports
Authoring and review support for Clinical Evaluation Reports, including literature appraisal, data analysis, residual risk justification, and alignment with EU MDR and MEDDEV expectations.
Clinical Evidence Strategy
Strategic planning for the right mix of literature, PMCF, investigation data, and real-world evidence to support safety, performance, and market-specific submission goals.
Submission Readiness
Structured assessments of documentation completeness, clinical evidence adequacy, risk file integrity, and traceability before FDA, EU MDR, TGA, or other submissions.
Risk Management Alignment
Support to align biological and clinical evaluation outputs with ISO 14971 risk management files, benefit-risk conclusions, and technical documentation narratives.
Gap Assessment
Detailed gap analysis against applicable regulatory requirements to identify missing evidence, weak justifications, and remediation priorities before authority review.
PMCF Adequacy Review
Evaluation of PMCF plans and reports to confirm methods, rationale, and outputs are proportionate, defensible, and suitable for ongoing clinical evaluation obligations.
Submission-Ready Evidence
Stronger Evidence for Safer Market Access
Biological and clinical evaluation work must do more than satisfy a checklist. It needs to show a coherent, evidence-based safety and performance story across risk management, technical documentation, and post-market obligations. Elexes helps manufacturers develop, review, and strengthen these critical evaluation outputs so submissions are clearer, more defensible, and better aligned with reviewer expectations across major regulatory frameworks.
Trusted By Manufacturers
Success Stories
See how manufacturers strengthen submissions and reduce regulatory friction with expert evaluation support.
“Excellent communication, diligent work. There is a strong quality background and QMS norms expertise.”
Samip Shah
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Accurate and amazing! Their regulatory-compliant fact sheets for multiple products enabled us to sell domestically and internationally without issues. Their work had an impressive turnaround time.”
Elizabeth W
“Highly recommended! They excelled at regulatory projects, and document control, and grasped our product’s nuances quickly.”
Michal Depa
“Excellent communication, diligent work. There is a strong quality background and QMS norms expertise.”
Samip Shah
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Accurate and amazing! Their regulatory-compliant fact sheets for multiple products enabled us to sell domestically and internationally without issues. Their work had an impressive turnaround time.”
Elizabeth W
“Highly recommended! They excelled at regulatory projects, and document control, and grasped our product’s nuances quickly.”
Michal Depa
“Excellent communication, diligent work. There is a strong quality background and QMS norms expertise.”
Samip Shah
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Accurate and amazing! Their regulatory-compliant fact sheets for multiple products enabled us to sell domestically and internationally without issues. Their work had an impressive turnaround time.”
Elizabeth W
“Highly recommended! They excelled at regulatory projects, and document control, and grasped our product’s nuances quickly.”
Michal Depa
The Elexes Difference
Why Choose Elexes?
Manufacturers rely on Elexes for rigorous, practical, and globally informed regulatory support.
Deep Expertise
50+ years of collective experience across regulatory, quality, and clinical medical device functions.
Global Coverage
Support spans FDA, EU MDR, TGA, Health Canada, and other major regulatory pathways.
Proven Results
250+ successful projects across 200+ product types with a 90% audit clearance rate.
Flexible Support
Project-based, part-time, or embedded models give teams expert help without added headcount.
Meet The Elexes Team
Experienced specialists supporting complex regulatory evidence needs.
Elexes Medical Consulting Pvt. Ltd. supports medical device manufacturers with end-to-end regulatory, quality, and clinical consulting across the product lifecycle. The company has become a trusted partner for organizations seeking stronger submissions, cleaner audits, and practical guidance through complex global requirements. Backed by 50+ years of collective experience, the Elexes team helps clients navigate biological evaluation, clinical evidence strategy, technical documentation, risk management alignment, and post-market obligations with a disciplined, submission-focused approach. With 250+ successful projects completed across 200+ product types and support delivered to clients in the USA, Europe, Canada, Australia, and beyond, Elexes is built to provide expert oversight, clear remediation pathways, and dependable execution where regulatory precision matters most.
250+ ProjectsSuccessful regulatory and compliance engagements delivered.200+ Product TypesExperience across diverse device categories and technologies.90% Audit ClearanceStrong track record in inspection and audit readiness.
Frequently Asked Questions
What is biological evaluation of medical devices?
Biological evaluation is the structured assessment of how a medical device interacts with the body to demonstrate biocompatibility and safety for its intended use. It typically considers device materials, nature and duration of contact, processing residues, toxicological risks, and applicable testing or justification strategies. The work is commonly aligned with ISO 10993 principles and integrated with risk management and technical documentation.
What is clinical evaluation of medical devices?
Clinical evaluation is the systematic assessment of clinical data to confirm that a medical device achieves its intended purpose and maintains an acceptable safety profile. It may include literature, clinical investigations, PMCF data, complaint trends, and real-world evidence. The output often supports regulatory submissions by linking clinical evidence, benefit-risk conclusions, and post-market findings into a defensible evaluation record.
When does a medical device need biological evaluation?
A device generally needs biological evaluation whenever it has direct or indirect patient contact, including skin, mucosal, blood, tissue, or implant contact. The scope depends on contact type, duration, materials, manufacturing processes, and whether the device has changed. Even when full testing is not required, manufacturers still need a documented rationale, risk-based assessment, and traceable evidence supporting biological safety.
What documents are typically included in a clinical evaluation package?
A clinical evaluation package often includes the clinical evaluation plan, literature search strategy, appraisal records, data analysis, benefit-risk conclusions, PMCF inputs where applicable, and the final Clinical Evaluation Report. It may also reference risk management files, PMS data, labeling, intended use statements, and technical documentation sections. Strong packages are internally consistent, traceable, and aligned with the target market’s regulatory expectations.
How do biological and clinical evaluations connect to risk management?
Biological and clinical evaluations should directly support the device risk management process rather than exist as standalone documents. Biological findings inform hazard identification and residual risk conclusions, while clinical evaluation confirms whether safety and performance remain acceptable in real-world use. Regulators expect these outputs to align with ISO 14971 risk files, labeling claims, PMS data, and the broader technical documentation narrative.
Can literature alone support a clinical evaluation?
In some cases, yes, but only when the literature is relevant, methodologically sound, and sufficiently representative of the device under evaluation. The evidence must support intended use, technological characteristics, clinical performance, and safety conclusions. For higher-risk, novel, or poorly documented devices, literature alone may be inadequate, and additional PMCF, clinical investigation data, or other evidence may be needed to close gaps.
What are common reasons clinical or biological evaluations get challenged by regulators?
Common issues include weak literature search methods, poor equivalence justification, missing traceability to risk management, outdated reports, unsupported conclusions, and gaps between claims and evidence. Regulators also challenge evaluations when biological endpoints are not justified, PMCF rationale is weak, or technical documentation is inconsistent. A structured readiness review can identify these weaknesses before submission and reduce avoidable deficiency questions.
How can Elexes help with biological and clinical evaluation of medical devices?
Elexes supports manufacturers with clinical evidence strategy, CER authoring and review, PMCF adequacy review, submission readiness assessments, gap analysis, and alignment of evaluation outputs with risk management and technical documentation. The team also helps remediate weak files before FDA, EU MDR, TGA, Health Canada, and other submissions. This approach helps reduce rework, improve defensibility, and support smoother regulatory interactions.
Still Need Evaluation Guidance?
Speak with our regulatory specialists about your evidence strategy.
Certified & Trusted
Awards and Recognition
ISO 13485
Medical device quality systems expertise.
MDSAP
Multi-market audit readiness support.
IEC 62304
Software lifecycle compliance capability.
